Cargando…
Engineering of Biocompatible Coacervate-Based Synthetic Cells
[Image: see text] Polymer-stabilized complex coacervate microdroplets have emerged as a robust platform for synthetic cell research. Their unique core–shell properties enable the sequestration of high concentrations of biologically relevant macromolecules and their subsequent release through the sem...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908014/ https://www.ncbi.nlm.nih.gov/pubmed/33587612 http://dx.doi.org/10.1021/acsami.0c19052 |
_version_ | 1783655616091258880 |
---|---|
author | van Stevendaal, Marleen H. M. E. Vasiukas, Laurynas Yewdall, N. Amy Mason, Alexander F. van Hest, Jan C. M. |
author_facet | van Stevendaal, Marleen H. M. E. Vasiukas, Laurynas Yewdall, N. Amy Mason, Alexander F. van Hest, Jan C. M. |
author_sort | van Stevendaal, Marleen H. M. E. |
collection | PubMed |
description | [Image: see text] Polymer-stabilized complex coacervate microdroplets have emerged as a robust platform for synthetic cell research. Their unique core–shell properties enable the sequestration of high concentrations of biologically relevant macromolecules and their subsequent release through the semipermeable membrane. These unique properties render the synthetic cell platform highly suitable for a range of biomedical applications, as long as its biocompatibility upon interaction with biological cells is ensured. The purpose of this study is to investigate how the structure and formulation of these coacervate-based synthetic cells impact the viability of several different cell lines. Through careful examination of the individual synthetic cell components, it became evident that the presence of free polycation and membrane-forming polymer had to be prevented to ensure cell viability. After closely examining the structure–toxicity relationship, a set of conditions could be found whereby no detrimental effects were observed, when the artificial cells were cocultured with RAW264.7 cells. This opens up a range of possibilities to use this modular system for biomedical applications and creates design rules for the next generation of coacervate-based, biomedically relevant particles. |
format | Online Article Text |
id | pubmed-7908014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-79080142021-02-26 Engineering of Biocompatible Coacervate-Based Synthetic Cells van Stevendaal, Marleen H. M. E. Vasiukas, Laurynas Yewdall, N. Amy Mason, Alexander F. van Hest, Jan C. M. ACS Appl Mater Interfaces [Image: see text] Polymer-stabilized complex coacervate microdroplets have emerged as a robust platform for synthetic cell research. Their unique core–shell properties enable the sequestration of high concentrations of biologically relevant macromolecules and their subsequent release through the semipermeable membrane. These unique properties render the synthetic cell platform highly suitable for a range of biomedical applications, as long as its biocompatibility upon interaction with biological cells is ensured. The purpose of this study is to investigate how the structure and formulation of these coacervate-based synthetic cells impact the viability of several different cell lines. Through careful examination of the individual synthetic cell components, it became evident that the presence of free polycation and membrane-forming polymer had to be prevented to ensure cell viability. After closely examining the structure–toxicity relationship, a set of conditions could be found whereby no detrimental effects were observed, when the artificial cells were cocultured with RAW264.7 cells. This opens up a range of possibilities to use this modular system for biomedical applications and creates design rules for the next generation of coacervate-based, biomedically relevant particles. American Chemical Society 2021-02-15 2021-02-24 /pmc/articles/PMC7908014/ /pubmed/33587612 http://dx.doi.org/10.1021/acsami.0c19052 Text en © 2021 The Authors. Published by American Chemical Society Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | van Stevendaal, Marleen H. M. E. Vasiukas, Laurynas Yewdall, N. Amy Mason, Alexander F. van Hest, Jan C. M. Engineering of Biocompatible Coacervate-Based Synthetic Cells |
title | Engineering of Biocompatible Coacervate-Based Synthetic
Cells |
title_full | Engineering of Biocompatible Coacervate-Based Synthetic
Cells |
title_fullStr | Engineering of Biocompatible Coacervate-Based Synthetic
Cells |
title_full_unstemmed | Engineering of Biocompatible Coacervate-Based Synthetic
Cells |
title_short | Engineering of Biocompatible Coacervate-Based Synthetic
Cells |
title_sort | engineering of biocompatible coacervate-based synthetic
cells |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908014/ https://www.ncbi.nlm.nih.gov/pubmed/33587612 http://dx.doi.org/10.1021/acsami.0c19052 |
work_keys_str_mv | AT vanstevendaalmarleenhme engineeringofbiocompatiblecoacervatebasedsyntheticcells AT vasiukaslaurynas engineeringofbiocompatiblecoacervatebasedsyntheticcells AT yewdallnamy engineeringofbiocompatiblecoacervatebasedsyntheticcells AT masonalexanderf engineeringofbiocompatiblecoacervatebasedsyntheticcells AT vanhestjancm engineeringofbiocompatiblecoacervatebasedsyntheticcells |